Your browser doesn't support javascript.
loading
METTL3-mediated ANXA2 inhibition confers neuroprotection in ischemic stroke: Evidence from in vivo and in vitro studies.
Liu, Bin; Xing, Zhiqun; Song, Feng; Li, Dejun; Zhao, Bao; Xu, Chunyang; Xia, Wenjun; Ji, Hongsheng.
Affiliation
  • Liu B; Department of Critical Care Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, P. R. China.
  • Xing Z; School of Medicine, Shandong University, Jinan, P. R. China.
  • Song F; Shandong University of Traditional Chinese Medicine, Jinan, P. R. China.
  • Li D; Department of Critical Care Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, P. R. China.
  • Zhao B; Department of Critical Care Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, P. R. China.
  • Xu C; Department of Critical Care Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, P. R. China.
  • Xia W; Department of Critical Care Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, P. R. China.
  • Ji H; Department of Critical Care Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, P. R. China.
FASEB J ; 37(7): e22974, 2023 07.
Article in En | MEDLINE | ID: mdl-37249328

Full text: 1 Database: MEDLINE Main subject: Brain Injuries / Brain Ischemia / Stroke / Ischemic Stroke Limits: Animals / Humans Language: En Year: 2023 Type: Article

Full text: 1 Database: MEDLINE Main subject: Brain Injuries / Brain Ischemia / Stroke / Ischemic Stroke Limits: Animals / Humans Language: En Year: 2023 Type: Article